Terns Pharmaceuticals (TERN)
(Real Time Quote from BATS)
$5.76 USD
+0.09 (1.59%)
Updated Aug 7, 2025 10:00 AM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Terns Pharmaceuticals, Inc. has a market cap of $496.19M, which represents its share price of $5.67 multiplied by its outstanding shares number of 87.51M. As a small-cap company, TERN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TERN 5.76 +0.09(1.59%)
Will TERN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TERN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TERN
Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)
TERN: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy
Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
Other News for TERN
Terns Pharma (TERN) Projects Financial Stability Until 2028 with Ongoing Trials
Terns Pharmaceuticals GAAP EPS of -$0.26 beats by $0.03
Terns Pharmaceuticals reports Q2 EPS (26c), consensus (29c)
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule ...
Commit To Buy Terns Pharmaceuticals At $3, Earn 23.3% Using Options